Literature DB >> 15934419

Aortic coarctation suspected by Doppler echocardiography of renal arteries in hypertensive patients referred to a hospital outpatient hypertension clinic.

Cesare Cuspidi1, Stefano Meani, Cristiana Valerio, Veronica Fusi, Eleonora Catini, Fabio Magrini, Alberto Zanchetti.   

Abstract

Coarctation of the aorta is the fourth most frequent form of congenital cardiovascular disease, which is diagnosed by the presence of higher blood pressures in the arms than in the legs. In this report we describe 3 cases of aortic coarctation, in which the correct diagnosis was suspected only months or years after the detection of hypertension, when a renal ultrasound examination was requested, despite the fact that the hallmarks of the disease were present at the physical examination in all patients. A marked reduction in renal flow velocities was suggestive of proximal aortic stenosis in all 3 cases. We conclude that the diagnosis of aortic coarctation, an uncommon but not so rare form of secondary hypertension, by renal ultrasonography rather than by a complete physical examination, reflects a commitment failure of physicians in everyday management of hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15934419

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  2 in total

1.  Diagnostic Value of Transthoracic Echocardiography in Patients with Coarctation of Aorta: The Chinese Experience in 53 Patients Studied between 2008 and 2012 in One Major Medical Center.

Authors:  Zhenxing Sun; Tsung O Cheng; Ling Li; Li Zhang; Xinfang Wang; Nianguo Dong; Qing Lv; Ke Li; Li Yuan; Jing Wang; Mingxing Xie
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

2.  Serendipitous diagnosis of aortic coarctation by bilateral parvus et tardus renal Doppler flow pattern.

Authors:  Mohammad Kazem Tarzamni; Nariman Nezami; Mohammad Reza Ardalan; Jalal Etemadi; Hamid Noshad; Fatemeh Gatreh Samani; Mehrnoush Toufan
Journal:  Cardiovasc Ultrasound       Date:  2007-11-26       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.